Genetics of male infertility: status and prospects by Eberhard Nieschlag et al.
ORAL PRESENTATION Open Access
Genetics of male infertility: status and prospects
Eberhard Nieschlag1,3*, Frank Tüttelmann2, Mohammed A. Beg3
From 2nd International Genomic Medical Conference (IGMC 2013)
Jeddah, Kingdom of Saudi Arabia. 24-27 November 2013
The incidence of infertility is about 15% in couples of
childbearing age. In half of these couples a fertility pro-
blem exists on the male side. However, causes of male
infertility are still to a large extent unknown. Today, in
about 20% of patients with azoospermia or severe oligo-
zoospermia genetic causes have been identified and
further progress is expected from genetic investigations.
The Klinefelter syndrome represents the most frequent
form of human aneuploidies and male infertility. The high
incidence of 1:500 in the general male population
increases to 1:50 in infertility centres. Ninety percent of
the affected men show azoospermia. In recent years it
became possible to obtain viable sperm by testicular
biopsy, followed by TESE/ICSI, resulting in pregnancies.
Since these sperm may derive from isolated spermatogonia
with a regular karyotype, most of the children have normal
karyotypes.
AZF a, b, and c deletions of the Y chromosome are
found in men with severe infertility. The incidence
among patients with very low sperm counts or azoosper-
mia varies between 2.5 and 10 %. From patients with
AZFc deletions sperm may be retrieved from testicular
biopsies and induction of pregnancy with these sperm is
possible by applying TESE/ICSI. Patients with AZF a and
b deletions mostly have complete Sertoli-cell-only-syn-
drome (SCOS) and have no chances for paternity. Male
children of men with microdeletions in the AZF region
have the same deletions as their fathers and are likely to
be infertile themselves.
Mutations of the CFTR gene affect functioning of the
chloride ion channels in the epithelial cell membranes
leading to cystic fibrosis and congenital bilateral absence
of the vas deferens (CBAVD). CBAVD may occur as a
minimal form of cystic fibrosis (CF). Before TESE/ICSI is
applied, the status of the female partner needs to be
determined in order to avoid offspring suffering from CF.
A number of genes mutated in isolated hypogonadotro-
pic hypogonadism (IHH) and Kallmann syndrome have
been identified Oligozoospermic men with combined sin-
gle nucleotide polymorphism of FSHR 2039A>G and
FSHB-211G>T may benefit from FSH therapy.
Although men may remain fertile lifelong, a slow decline
of reproductive capacities occurs beyond the age of 45 and
specific gene mutations e.g. of the FGFR2 and FGRF3
genes causing Apert syndrome and achondroplasia may
increase, affecting offspring.
Investigations into epigenetics such as methylation
abnormalities, transcriptome analysis as well as single and
combined single-nucleotide polymorphism genotypes and
whole genome analysis in individual sperm may lead to
the identification of further genetic associations with
infertility.
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